SlideShare a Scribd company logo
Lifecycle Management of
Analytical Procedures
How the modern concept of a lifecycle model can be applied to analytical procedures.
Chandra Prakash Singh
Analytical Procedures
(Traditional approaches)
Method
Development
Method
Validation
Method
Transfer
Analytical
Procedures
(Lifecycle
approaches)
Method
Development
Method
Validation
Method
Transfer
Validation, transfer, and verification should be integrated
into the analytical procedure lifecycle process rather
than being viewed as separate entities.
Analytical Procedures
Provide guidance pertaining to procedure suitability
as a part of procedure validation exercise.
Don't provide a framework that allows users to
reliably understand and control source of variability.
In alignment with process validation, three stages are proposed
Procedure Design
(Development and
understanding)
Procedure
Performance
Qualification
Continued Procedure
Performance Verification
A fundamental component of the lifecycle approach to analytical procedures is
having a predefined objective that stipulates the performance requirements for
the analytical procedure. These requirements are derived from the Analytical
Target Profile (ATP).
Lifecycle model
Process
validation
ICH guidelines Q8,
Q9, and Q10
Lifecycle Model
Any analytical procedure must be shown to be fit for its intended purpose before use.
The concept of QbD is understood as a “systematic approach that begins with
predefined objectives and emphasizes product and process understanding
and process control, based on sound science and quality risk management”.
Lifecycle Principles
Adoption of lifecycle
approach would
introduce new
concepts
The Analytical Target Profile and associated
predefined acceptance criteria.
Evaluation of the uncertainty associated with the
analytical procedure.
Incorporation of risk analysis strategies.
Consideration of the potential effect of changes to an
analytical procedure in the context of the analytical
procedure's lifecycle
Cornerstone concepts in
lifecycle management
The Analytical Target
Profile (ATP)
Risk management Control strategy
Knowledge
management
The Lifecycle Management
The Analytical Target Profile (ATP)
• The objective of the test and quality requirements, including the expected
level of confidence, for the reportable result that allows the correct conclusion
to be drawn regarding the attributes of the material that is being measured.
Defines
• The understanding of the target measurement uncertainty, which is the
maximum uncertainty that the data should have in order to maintain
acceptable levels of confidence in data quality.
Based on
• A reference point for assessing the fitness of an analytical procedure not only
in the development phase but also during all changes within the analytical
lifecycle.
Serves as
The Analytical Target Profile (ATP)
• The procedure must be able to accurately quantify [drug] in a range from [A units] to [B
units] in the [description of test article] in the presence of [x, y, z] with an accuracy =
100% ± [D%] and a precision ≤ [E%] for the reportable value.
Example 1:
• The procedure must be able to quantify [analyte] in a range from [A units] to [B units] in
the [description of test article] in the presence of [x, y, z] so that the distribution of the
total analytical error of the reportable value falls within the total allowable analytical
error range of ± [C%].
Example 2:
The second example species that the combined accuracy and precision, or the distribution
of the total analytical error (TAE), must fall within the desired level.
Risk Management
QRM for analytical procedures
Systematic process for the
• Assessment
• Control
• Communication
• Review of risks
To the quality of data across the
product lifecycle.
Identification of
Variables
The variables should
include all aspects of
the full analytical
procedure
Sampling
Sample preparation
Standards
Reagents
Facility
Equipment operating conditions.
The identified
variables
Should be evaluated using
appropriate risk-assessment tools
and prioritized experimentation
To understand,
eliminate, or mitigate
areas of risk.
Risk Management
CNX approach
C=Control,
N=Noise,
E=Experimental
A decision can be
made concerning
Which variables should be controlled (C)
Which are potential noise factors (N)
Which should be examined experimentally
(X)
To classify all
identified variables.
To determine
acceptable
ranges.
Risk Management
Risk-analysis and DOE
Risk-analysis tools can
be used to screen
experimental (X)
variables for DOE
studies to minimize the
total number of
experiments conducted
while maximizing
knowledge gained.
The results of DOE studies
provide justification of the
critical variables and their
acceptable ranges (from the risk
assessment and experimental
work), are inputs in the
Analytical Control Strategy, and
are explicitly specified in the
analytical procedure.
.
Analytical
Procedure
Variability
Sample
Sampling
Sample Preparation
Standard
Reagents
Analysis
Analytical Measurement
Equipment operating conditions
Reportable
Results
Data processing
Strategy for CI (number of
replicates, averaging, etc.)
Analytical Procedure
Control Strategy
Risk
Assessment
Analytical Procedure to Consider for Risk Assessment and Control Strategy
Quality risk
management,
control
strategy, and
knowledge
management:
how they work
together.
Identify as many variables as possible
(prior knowledge)
Assign risk based on potential impact
on data precision and accuracy
(risk identification).
The variables identified to have impact
on the data will be subject to DOE
(risk evaluation).
This leads to process understanding.
Based on the process understanding
risk control.
Risk reduction
Risk acceptance
Risk unacceptable
Risk review (routine monitoring)
Continuous
improvement
Deviations from ATP*
*(Unfavourable trend, Potentially result of a change in one or more variables).
Advantages of Adopting a Lifecycle Approach for Managing Analytical Procedures
Knowledgemanagement
Control
Strategy
Iterative
Risk Communication
Lifecycle
Stages
Stage 1: Procedure
Design
Procedure Development and Understanding
(Identify and Study Potential Analytical Variables)
Experimental Robustness Studies
Knowledge Gathering and Preparation
Stage 2: Procedure
Performance
Qualification
Stage 3: Continued
Procedure
Performance
Verification
Routine Monitoring
Observed Variations
Continual Improvement
Lifecycle Stages
In order to
provide a
holistic
approach to
controlling an
analytical
procedure
throughout its
lifecycle.
Common Variation and Special Variation
Upper Limit
Lower Limit
Unacceptable common
cause variation
Special cause
variation
Fit for purpose –
common cause variation
is acceptable and no
special cause variation
Observed Variations During the investigation, particular attention should be given to special cause variation
(shifts, drift, and deviation) and common cause variation (unacceptable noise).
Observed Variations
Variation may
result when a
particular
procedure variable
is not adequately
controlled. This
variation may arise
for a number of
reasons:
A variable was not identified or adequately studied during the procedure
understanding study (Stage 1), and therefore no proper control was defined.
A variable was not identified or adequately studied during Stage 2 (precision
study), and therefore no proper control was defined.
Series member of a set of categorical variables (not included in the DoE, Stage 1)
has been found to have an effect on performance (e.g., a new batch of column
packing results in unacceptable performance).
A control strategy was defined but not followed.
A noise variable has been found to have an impact on routine performance.
Change
Type 1:
• Changes that are within already proven ranges (within the procedure's design space) are considered
adjustments and do not require a procedure performance qualification study to be performed before
returning to routine monitoring.
Change
Type 2:
• These are changes that are outside the already proven ranges but require only confirmation that the
procedure continues to generate data that meet ATP requirements. Full procedure redevelopment is not
required.
Change
Type 3:
• These are changes that involve the need to operate the analytical procedure in a different environment.
These types of changes traditionally have been treated as a procedure-transfer exercise (or procedure
verification when a pharmacopeial procedure is used for the first time in a new environment).
Change
Type 4:
• This is a change that may require a new analytical procedure, but the ATP remains the same. The
procedure will return to the procedure development stage.
Change
Type 5:
• This change involves tightening a specification limit or a change to the intended purpose of the procedure
to measure additional attributes. These changes result in a new ATP being defined.
Continual Improvement - Example of changes and appropriate actions
Three Stages in Proposed Lifecycle Approach
Input of Design
Procedure
development
Identify Potential Analytical
Variables
• Continuous Variables
• Categorical Variables
Experimental Robustness Study
Analytical Procedures PPQ Protocol
Experimental studies to
demonstrate “fitness of purpose”
(including local noise factor).
PPQ Report and local analytical
control strategy including the
formal procedure.
Routine
Monitoring
Action
Trigger
Investigation
and CAPP
Special Cause
Variation
Risk
Assessment
Unacceptable
common cause
variation
Continuous
improvement
Stage-1: Procedure Design
Development and Understanding
Stage-2: Procedure Performance
Qualification
Stage-3:
Procedure Verification
Knowledge gathering and preparation (when a procedure
is used in a new location)
Change Type 1
Change Type 2
Change Type 3
Change Type 4
Change Type 5
Current Approach
• Focus is showing that various procedure
performance characteristics meet criteria—
but may not consider how these relate to the
overall uncertainty in the data and whether
they are acceptable or not.
Lifecycle Approach
• The driver is understanding the target
measurement uncertainty, which is the
maximum level of measurement uncertainty
that represents fitness for purpose (i.e.,
ensures decisions from data are made with a
predefined confidence) and to demonstrate
the procedure will meet this uncertainty
requirement.
Current Approach
• Tendency to perform validation in a check
box manner against the general analytical
performance characteristics described in and
ICH Q2.
Lifecycle Approach
• Specific ATP for each measurement
requirement defining the characteristics and
criteria that the procedure should meet.
Advantages of Adopting a Lifecycle Approach for Managing Analytical Procedures
Current Approach
• Limited understanding of effects of variation
on performance. Lifecycle Approach
• Structured and methodological approach to
identify and explore variables.
Current Approach
• Validation, verification, and transfer are
seen as separate exercises.
Lifecycle Approach
• All are integrated as part of the analytical
procedure lifecycle, and success is
demonstrated by generating reportable
results that are consistent with the ATP.
Advantages of Adopting a Lifecycle Approach for Managing Analytical Procedures
Current Approach
• Confusion about the differences among
procedure validation, procedure transfer,
and procedure verification.
Lifecycle Approach
• Improved clarity and holistic view with the
ATP as the focal point.
?
Thanks

More Related Content

What's hot

USFDA guidelines for bioanalytical method validation
USFDA guidelines for bioanalytical method validationUSFDA guidelines for bioanalytical method validation
USFDA guidelines for bioanalytical method validation
bhatiaji123
 
Analytical Method Validation.pptx
Analytical Method Validation.pptxAnalytical Method Validation.pptx
Analytical Method Validation.pptx
Bholakant raut
 
Analytical Target Profile (ATP) - Structure and Application Throughout the An...
Analytical Target Profile (ATP) - Structure and Application Throughout the An...Analytical Target Profile (ATP) - Structure and Application Throughout the An...
Analytical Target Profile (ATP) - Structure and Application Throughout the An...
pi
 
Bioanalytical method validation - Global regulatory chalenges
Bioanalytical method validation - Global regulatory chalengesBioanalytical method validation - Global regulatory chalenges
Bioanalytical method validation - Global regulatory chalenges
Peter van Amsterdam
 
Qualification of instrumets
Qualification of instrumetsQualification of instrumets
Qualification of instrumets
ChowdaryPavani
 
Analytical Method Validation
Analytical Method ValidationAnalytical Method Validation
Analytical Method Validation
Soumyadarshi Choudhury
 
45160177 forced-degradation
45160177 forced-degradation45160177 forced-degradation
45160177 forced-degradationAmit Shah
 
Impurities in drug substance (ich q3 a)
Impurities in drug substance (ich q3 a)Impurities in drug substance (ich q3 a)
Impurities in drug substance (ich q3 a)
Bhanu Chava
 
Method development and validation in HPLC
Method development and validation in HPLCMethod development and validation in HPLC
Method development and validation in HPLC
coolprashant33
 
Q2 r1 guidelines
Q2 r1 guidelinesQ2 r1 guidelines
Q2 r1 guidelines
upalkarsapana
 
Degradation study and analysis of impurities
Degradation study and analysis of impuritiesDegradation study and analysis of impurities
Degradation study and analysis of impurities
Yachita Rajwadwala
 
Karl Fischer Titration (KF titration)
Karl Fischer Titration (KF titration)Karl Fischer Titration (KF titration)
Karl Fischer Titration (KF titration)
Sajjad Ullah
 
Analytical Method Validation basics by Dr. A. Amsavel
Analytical Method Validation  basics by Dr. A. AmsavelAnalytical Method Validation  basics by Dr. A. Amsavel
Analytical Method Validation basics by Dr. A. Amsavel
Dr. Amsavel A
 
Bioanalytical Method Validation
Bioanalytical Method ValidationBioanalytical Method Validation
Bioanalytical Method Validation
Rahul Naudiyal
 
Qualification of laboratory equipments by Mayuri Soni
Qualification of laboratory equipments by Mayuri SoniQualification of laboratory equipments by Mayuri Soni
Qualification of laboratory equipments by Mayuri Soni
Mayuri Soni
 
HPLC validation.ppt
HPLC validation.pptHPLC validation.ppt
HPLC validation.ppt
Priyanka Yadav
 
Qualification of High Performance Liquid Chromatography(HPLC)
Qualification of High Performance Liquid Chromatography(HPLC)Qualification of High Performance Liquid Chromatography(HPLC)
Qualification of High Performance Liquid Chromatography(HPLC)
PRAVADA
 
ICH guidelines on impurities in new drug products.pptx
ICH guidelines on impurities in new drug products.pptxICH guidelines on impurities in new drug products.pptx
ICH guidelines on impurities in new drug products.pptx
Divya Pushp
 
Q3A(R2) IMPURITIES IN NEW DRUG SUBSTANCES
Q3A(R2)  IMPURITIES IN NEW DRUG SUBSTANCESQ3A(R2)  IMPURITIES IN NEW DRUG SUBSTANCES
Q3A(R2) IMPURITIES IN NEW DRUG SUBSTANCES
Muhamad Abdalkader
 
HPLC Trouble Shotting
HPLC  Trouble ShottingHPLC  Trouble Shotting
HPLC Trouble Shotting
Manish Kumar
 

What's hot (20)

USFDA guidelines for bioanalytical method validation
USFDA guidelines for bioanalytical method validationUSFDA guidelines for bioanalytical method validation
USFDA guidelines for bioanalytical method validation
 
Analytical Method Validation.pptx
Analytical Method Validation.pptxAnalytical Method Validation.pptx
Analytical Method Validation.pptx
 
Analytical Target Profile (ATP) - Structure and Application Throughout the An...
Analytical Target Profile (ATP) - Structure and Application Throughout the An...Analytical Target Profile (ATP) - Structure and Application Throughout the An...
Analytical Target Profile (ATP) - Structure and Application Throughout the An...
 
Bioanalytical method validation - Global regulatory chalenges
Bioanalytical method validation - Global regulatory chalengesBioanalytical method validation - Global regulatory chalenges
Bioanalytical method validation - Global regulatory chalenges
 
Qualification of instrumets
Qualification of instrumetsQualification of instrumets
Qualification of instrumets
 
Analytical Method Validation
Analytical Method ValidationAnalytical Method Validation
Analytical Method Validation
 
45160177 forced-degradation
45160177 forced-degradation45160177 forced-degradation
45160177 forced-degradation
 
Impurities in drug substance (ich q3 a)
Impurities in drug substance (ich q3 a)Impurities in drug substance (ich q3 a)
Impurities in drug substance (ich q3 a)
 
Method development and validation in HPLC
Method development and validation in HPLCMethod development and validation in HPLC
Method development and validation in HPLC
 
Q2 r1 guidelines
Q2 r1 guidelinesQ2 r1 guidelines
Q2 r1 guidelines
 
Degradation study and analysis of impurities
Degradation study and analysis of impuritiesDegradation study and analysis of impurities
Degradation study and analysis of impurities
 
Karl Fischer Titration (KF titration)
Karl Fischer Titration (KF titration)Karl Fischer Titration (KF titration)
Karl Fischer Titration (KF titration)
 
Analytical Method Validation basics by Dr. A. Amsavel
Analytical Method Validation  basics by Dr. A. AmsavelAnalytical Method Validation  basics by Dr. A. Amsavel
Analytical Method Validation basics by Dr. A. Amsavel
 
Bioanalytical Method Validation
Bioanalytical Method ValidationBioanalytical Method Validation
Bioanalytical Method Validation
 
Qualification of laboratory equipments by Mayuri Soni
Qualification of laboratory equipments by Mayuri SoniQualification of laboratory equipments by Mayuri Soni
Qualification of laboratory equipments by Mayuri Soni
 
HPLC validation.ppt
HPLC validation.pptHPLC validation.ppt
HPLC validation.ppt
 
Qualification of High Performance Liquid Chromatography(HPLC)
Qualification of High Performance Liquid Chromatography(HPLC)Qualification of High Performance Liquid Chromatography(HPLC)
Qualification of High Performance Liquid Chromatography(HPLC)
 
ICH guidelines on impurities in new drug products.pptx
ICH guidelines on impurities in new drug products.pptxICH guidelines on impurities in new drug products.pptx
ICH guidelines on impurities in new drug products.pptx
 
Q3A(R2) IMPURITIES IN NEW DRUG SUBSTANCES
Q3A(R2)  IMPURITIES IN NEW DRUG SUBSTANCESQ3A(R2)  IMPURITIES IN NEW DRUG SUBSTANCES
Q3A(R2) IMPURITIES IN NEW DRUG SUBSTANCES
 
HPLC Trouble Shotting
HPLC  Trouble ShottingHPLC  Trouble Shotting
HPLC Trouble Shotting
 

Similar to Analytical procedures life cycle management

Quality control
Quality controlQuality control
Quality control
Pavalaveelzi C.M
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
roshankhetade2
 
PHARMACEUTICAL VALIDATION
PHARMACEUTICAL VALIDATIONPHARMACEUTICAL VALIDATION
PHARMACEUTICAL VALIDATION
JayeshRajput7
 
All you know About Analytical method validation
All you  know About Analytical method validation All you  know About Analytical method validation
All you know About Analytical method validation
CynthiaCynthiaPLegro
 
Pharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptxPharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptx
manoharkasde123
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
Tausif Momin
 
General Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdfGeneral Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdf
TamannaKumari8
 
Analytical control strategy 4
Analytical control strategy 4Analytical control strategy 4
Analytical control strategy 4
Chandra Prakash Singh
 
Q2methodvalidation 161105173750
Q2methodvalidation 161105173750Q2methodvalidation 161105173750
Q2methodvalidation 161105173750
ChristianReckziegel1
 
Analytical methods validation as per ich & usp
Analytical methods validation as per ich & uspAnalytical methods validation as per ich & usp
Analytical methods validation as per ich & usp
GANESH NIGADE
 
5-Scientific Approach to Validation.pptx
5-Scientific Approach to Validation.pptx5-Scientific Approach to Validation.pptx
5-Scientific Approach to Validation.pptx
AllanThomas30
 
Analytical quality by design
Analytical quality by designAnalytical quality by design
Analytical quality by design
Annalisa Forlenza
 
bio statistical tools of process validation
bio statistical tools of process validationbio statistical tools of process validation
bio statistical tools of process validation
mounika chowdary
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
SUBHASISH DAS
 
Analytical Method Validation.pdf
Analytical Method Validation.pdfAnalytical Method Validation.pdf
Analytical Method Validation.pdf
HiteshGajjar7
 
Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...
Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...
Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...
ShopnilAkash5
 
Validation of Analytical Methods.pdf
Validation of Analytical Methods.pdfValidation of Analytical Methods.pdf
Validation of Analytical Methods.pdf
anjaneyulu49
 
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and DefinitionsVALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
Chandra Prakash Singh
 
ICH-Q2 AMV
ICH-Q2 AMVICH-Q2 AMV
ICH-Q2 AMV
NIHASULTANA2
 
Analytical Methods Validation| PV M Pharmacy QA
Analytical Methods Validation| PV M Pharmacy QAAnalytical Methods Validation| PV M Pharmacy QA
Analytical Methods Validation| PV M Pharmacy QA
Ghanshyam Nawale
 

Similar to Analytical procedures life cycle management (20)

Quality control
Quality controlQuality control
Quality control
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
PHARMACEUTICAL VALIDATION
PHARMACEUTICAL VALIDATIONPHARMACEUTICAL VALIDATION
PHARMACEUTICAL VALIDATION
 
All you know About Analytical method validation
All you  know About Analytical method validation All you  know About Analytical method validation
All you know About Analytical method validation
 
Pharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptxPharmaceutical validation QA I Year.pptx
Pharmaceutical validation QA I Year.pptx
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
General Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdfGeneral Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdf
 
Analytical control strategy 4
Analytical control strategy 4Analytical control strategy 4
Analytical control strategy 4
 
Q2methodvalidation 161105173750
Q2methodvalidation 161105173750Q2methodvalidation 161105173750
Q2methodvalidation 161105173750
 
Analytical methods validation as per ich & usp
Analytical methods validation as per ich & uspAnalytical methods validation as per ich & usp
Analytical methods validation as per ich & usp
 
5-Scientific Approach to Validation.pptx
5-Scientific Approach to Validation.pptx5-Scientific Approach to Validation.pptx
5-Scientific Approach to Validation.pptx
 
Analytical quality by design
Analytical quality by designAnalytical quality by design
Analytical quality by design
 
bio statistical tools of process validation
bio statistical tools of process validationbio statistical tools of process validation
bio statistical tools of process validation
 
Analytical method validation
Analytical method validationAnalytical method validation
Analytical method validation
 
Analytical Method Validation.pdf
Analytical Method Validation.pdfAnalytical Method Validation.pdf
Analytical Method Validation.pdf
 
Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...
Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...
Pharmaceutical Instrument and Analytical Validation and Qualification (SHOPNI...
 
Validation of Analytical Methods.pdf
Validation of Analytical Methods.pdfValidation of Analytical Methods.pdf
Validation of Analytical Methods.pdf
 
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and DefinitionsVALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2) and Q14 - Terms and Definitions
 
ICH-Q2 AMV
ICH-Q2 AMVICH-Q2 AMV
ICH-Q2 AMV
 
Analytical Methods Validation| PV M Pharmacy QA
Analytical Methods Validation| PV M Pharmacy QAAnalytical Methods Validation| PV M Pharmacy QA
Analytical Methods Validation| PV M Pharmacy QA
 

More from Chandra Prakash Singh

VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)
Chandra Prakash Singh
 
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)
Chandra Prakash Singh
 
Currently Identified Risk Factors for Presence of Nitrosamines.pptx
Currently Identified Risk Factors for Presence of Nitrosamines.pptxCurrently Identified Risk Factors for Presence of Nitrosamines.pptx
Currently Identified Risk Factors for Presence of Nitrosamines.pptx
Chandra Prakash Singh
 
LCMS_BASIC UNDERSTANDING.pdf
LCMS_BASIC UNDERSTANDING.pdfLCMS_BASIC UNDERSTANDING.pdf
LCMS_BASIC UNDERSTANDING.pdf
Chandra Prakash Singh
 
LCMS Type of Scan.pdf
LCMS Type of Scan.pdfLCMS Type of Scan.pdf
LCMS Type of Scan.pdf
Chandra Prakash Singh
 
X-Rays The basic understanding of XRD analysis
X-Rays The basic understanding of XRD analysisX-Rays The basic understanding of XRD analysis
X-Rays The basic understanding of XRD analysis
Chandra Prakash Singh
 
X-RAY POWDER DIFFRACTION (XRPD).pptx
X-RAY POWDER DIFFRACTION (XRPD).pptxX-RAY POWDER DIFFRACTION (XRPD).pptx
X-RAY POWDER DIFFRACTION (XRPD).pptx
Chandra Prakash Singh
 
Triplus500 HS working.pptx
Triplus500 HS working.pptxTriplus500 HS working.pptx
Triplus500 HS working.pptx
Chandra Prakash Singh
 
LCMS - Ion Optics Path and Parameters.pptx
LCMS - Ion Optics Path and Parameters.pptxLCMS - Ion Optics Path and Parameters.pptx
LCMS - Ion Optics Path and Parameters.pptx
Chandra Prakash Singh
 
Diverter Valve.pptx
Diverter Valve.pptxDiverter Valve.pptx
Diverter Valve.pptx
Chandra Prakash Singh
 
LCMS_interface.pptx
LCMS_interface.pptxLCMS_interface.pptx
LCMS_interface.pptx
Chandra Prakash Singh
 
Fitness for use part 1
Fitness for use part 1Fitness for use part 1
Fitness for use part 1
Chandra Prakash Singh
 
Analytical control strategy 3
Analytical control strategy 3Analytical control strategy 3
Analytical control strategy 3
Chandra Prakash Singh
 
Analytical control strategy 2
Analytical control strategy 2Analytical control strategy 2
Analytical control strategy 2
Chandra Prakash Singh
 
Analytical control strategy 1
Analytical control strategy 1Analytical control strategy 1
Analytical control strategy 1
Chandra Prakash Singh
 
FID detector
FID detectorFID detector
FID detector
Chandra Prakash Singh
 
HPLC Column
HPLC ColumnHPLC Column
Acid base equilibria and reversed phase retention
Acid base equilibria and reversed phase retentionAcid base equilibria and reversed phase retention
Acid base equilibria and reversed phase retention
Chandra Prakash Singh
 
System suitability
System suitabilitySystem suitability
System suitability
Chandra Prakash Singh
 
Linearity cochran test
Linearity cochran testLinearity cochran test
Linearity cochran test
Chandra Prakash Singh
 

More from Chandra Prakash Singh (20)

VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)
VALIDATION OF ANALYTICAL PROCEDURES Q2(R2)
 
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)
 
Currently Identified Risk Factors for Presence of Nitrosamines.pptx
Currently Identified Risk Factors for Presence of Nitrosamines.pptxCurrently Identified Risk Factors for Presence of Nitrosamines.pptx
Currently Identified Risk Factors for Presence of Nitrosamines.pptx
 
LCMS_BASIC UNDERSTANDING.pdf
LCMS_BASIC UNDERSTANDING.pdfLCMS_BASIC UNDERSTANDING.pdf
LCMS_BASIC UNDERSTANDING.pdf
 
LCMS Type of Scan.pdf
LCMS Type of Scan.pdfLCMS Type of Scan.pdf
LCMS Type of Scan.pdf
 
X-Rays The basic understanding of XRD analysis
X-Rays The basic understanding of XRD analysisX-Rays The basic understanding of XRD analysis
X-Rays The basic understanding of XRD analysis
 
X-RAY POWDER DIFFRACTION (XRPD).pptx
X-RAY POWDER DIFFRACTION (XRPD).pptxX-RAY POWDER DIFFRACTION (XRPD).pptx
X-RAY POWDER DIFFRACTION (XRPD).pptx
 
Triplus500 HS working.pptx
Triplus500 HS working.pptxTriplus500 HS working.pptx
Triplus500 HS working.pptx
 
LCMS - Ion Optics Path and Parameters.pptx
LCMS - Ion Optics Path and Parameters.pptxLCMS - Ion Optics Path and Parameters.pptx
LCMS - Ion Optics Path and Parameters.pptx
 
Diverter Valve.pptx
Diverter Valve.pptxDiverter Valve.pptx
Diverter Valve.pptx
 
LCMS_interface.pptx
LCMS_interface.pptxLCMS_interface.pptx
LCMS_interface.pptx
 
Fitness for use part 1
Fitness for use part 1Fitness for use part 1
Fitness for use part 1
 
Analytical control strategy 3
Analytical control strategy 3Analytical control strategy 3
Analytical control strategy 3
 
Analytical control strategy 2
Analytical control strategy 2Analytical control strategy 2
Analytical control strategy 2
 
Analytical control strategy 1
Analytical control strategy 1Analytical control strategy 1
Analytical control strategy 1
 
FID detector
FID detectorFID detector
FID detector
 
HPLC Column
HPLC ColumnHPLC Column
HPLC Column
 
Acid base equilibria and reversed phase retention
Acid base equilibria and reversed phase retentionAcid base equilibria and reversed phase retention
Acid base equilibria and reversed phase retention
 
System suitability
System suitabilitySystem suitability
System suitability
 
Linearity cochran test
Linearity cochran testLinearity cochran test
Linearity cochran test
 

Recently uploaded

Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Academy of Science of South Africa
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
goswamiyash170123
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
TechSoup
 
JEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questionsJEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questions
ShivajiThube2
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
Wasim Ak
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 

Recently uploaded (20)

Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
 
JEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questionsJEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questions
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 

Analytical procedures life cycle management

  • 1. Lifecycle Management of Analytical Procedures How the modern concept of a lifecycle model can be applied to analytical procedures. Chandra Prakash Singh
  • 2. Analytical Procedures (Traditional approaches) Method Development Method Validation Method Transfer Analytical Procedures (Lifecycle approaches) Method Development Method Validation Method Transfer Validation, transfer, and verification should be integrated into the analytical procedure lifecycle process rather than being viewed as separate entities. Analytical Procedures Provide guidance pertaining to procedure suitability as a part of procedure validation exercise. Don't provide a framework that allows users to reliably understand and control source of variability.
  • 3. In alignment with process validation, three stages are proposed Procedure Design (Development and understanding) Procedure Performance Qualification Continued Procedure Performance Verification A fundamental component of the lifecycle approach to analytical procedures is having a predefined objective that stipulates the performance requirements for the analytical procedure. These requirements are derived from the Analytical Target Profile (ATP). Lifecycle model Process validation ICH guidelines Q8, Q9, and Q10 Lifecycle Model Any analytical procedure must be shown to be fit for its intended purpose before use. The concept of QbD is understood as a “systematic approach that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management”.
  • 4. Lifecycle Principles Adoption of lifecycle approach would introduce new concepts The Analytical Target Profile and associated predefined acceptance criteria. Evaluation of the uncertainty associated with the analytical procedure. Incorporation of risk analysis strategies. Consideration of the potential effect of changes to an analytical procedure in the context of the analytical procedure's lifecycle
  • 5. Cornerstone concepts in lifecycle management The Analytical Target Profile (ATP) Risk management Control strategy Knowledge management The Lifecycle Management
  • 6. The Analytical Target Profile (ATP) • The objective of the test and quality requirements, including the expected level of confidence, for the reportable result that allows the correct conclusion to be drawn regarding the attributes of the material that is being measured. Defines • The understanding of the target measurement uncertainty, which is the maximum uncertainty that the data should have in order to maintain acceptable levels of confidence in data quality. Based on • A reference point for assessing the fitness of an analytical procedure not only in the development phase but also during all changes within the analytical lifecycle. Serves as
  • 7. The Analytical Target Profile (ATP) • The procedure must be able to accurately quantify [drug] in a range from [A units] to [B units] in the [description of test article] in the presence of [x, y, z] with an accuracy = 100% ± [D%] and a precision ≤ [E%] for the reportable value. Example 1: • The procedure must be able to quantify [analyte] in a range from [A units] to [B units] in the [description of test article] in the presence of [x, y, z] so that the distribution of the total analytical error of the reportable value falls within the total allowable analytical error range of ± [C%]. Example 2: The second example species that the combined accuracy and precision, or the distribution of the total analytical error (TAE), must fall within the desired level.
  • 8. Risk Management QRM for analytical procedures Systematic process for the • Assessment • Control • Communication • Review of risks To the quality of data across the product lifecycle. Identification of Variables The variables should include all aspects of the full analytical procedure Sampling Sample preparation Standards Reagents Facility Equipment operating conditions.
  • 9. The identified variables Should be evaluated using appropriate risk-assessment tools and prioritized experimentation To understand, eliminate, or mitigate areas of risk. Risk Management CNX approach C=Control, N=Noise, E=Experimental A decision can be made concerning Which variables should be controlled (C) Which are potential noise factors (N) Which should be examined experimentally (X) To classify all identified variables. To determine acceptable ranges.
  • 10. Risk Management Risk-analysis and DOE Risk-analysis tools can be used to screen experimental (X) variables for DOE studies to minimize the total number of experiments conducted while maximizing knowledge gained. The results of DOE studies provide justification of the critical variables and their acceptable ranges (from the risk assessment and experimental work), are inputs in the Analytical Control Strategy, and are explicitly specified in the analytical procedure.
  • 11. . Analytical Procedure Variability Sample Sampling Sample Preparation Standard Reagents Analysis Analytical Measurement Equipment operating conditions Reportable Results Data processing Strategy for CI (number of replicates, averaging, etc.) Analytical Procedure Control Strategy Risk Assessment Analytical Procedure to Consider for Risk Assessment and Control Strategy
  • 12. Quality risk management, control strategy, and knowledge management: how they work together. Identify as many variables as possible (prior knowledge) Assign risk based on potential impact on data precision and accuracy (risk identification). The variables identified to have impact on the data will be subject to DOE (risk evaluation). This leads to process understanding. Based on the process understanding risk control. Risk reduction Risk acceptance Risk unacceptable Risk review (routine monitoring) Continuous improvement Deviations from ATP* *(Unfavourable trend, Potentially result of a change in one or more variables). Advantages of Adopting a Lifecycle Approach for Managing Analytical Procedures Knowledgemanagement Control Strategy Iterative Risk Communication
  • 13. Lifecycle Stages Stage 1: Procedure Design Procedure Development and Understanding (Identify and Study Potential Analytical Variables) Experimental Robustness Studies Knowledge Gathering and Preparation Stage 2: Procedure Performance Qualification Stage 3: Continued Procedure Performance Verification Routine Monitoring Observed Variations Continual Improvement Lifecycle Stages In order to provide a holistic approach to controlling an analytical procedure throughout its lifecycle.
  • 14. Common Variation and Special Variation Upper Limit Lower Limit Unacceptable common cause variation Special cause variation Fit for purpose – common cause variation is acceptable and no special cause variation Observed Variations During the investigation, particular attention should be given to special cause variation (shifts, drift, and deviation) and common cause variation (unacceptable noise).
  • 15. Observed Variations Variation may result when a particular procedure variable is not adequately controlled. This variation may arise for a number of reasons: A variable was not identified or adequately studied during the procedure understanding study (Stage 1), and therefore no proper control was defined. A variable was not identified or adequately studied during Stage 2 (precision study), and therefore no proper control was defined. Series member of a set of categorical variables (not included in the DoE, Stage 1) has been found to have an effect on performance (e.g., a new batch of column packing results in unacceptable performance). A control strategy was defined but not followed. A noise variable has been found to have an impact on routine performance.
  • 16. Change Type 1: • Changes that are within already proven ranges (within the procedure's design space) are considered adjustments and do not require a procedure performance qualification study to be performed before returning to routine monitoring. Change Type 2: • These are changes that are outside the already proven ranges but require only confirmation that the procedure continues to generate data that meet ATP requirements. Full procedure redevelopment is not required. Change Type 3: • These are changes that involve the need to operate the analytical procedure in a different environment. These types of changes traditionally have been treated as a procedure-transfer exercise (or procedure verification when a pharmacopeial procedure is used for the first time in a new environment). Change Type 4: • This is a change that may require a new analytical procedure, but the ATP remains the same. The procedure will return to the procedure development stage. Change Type 5: • This change involves tightening a specification limit or a change to the intended purpose of the procedure to measure additional attributes. These changes result in a new ATP being defined. Continual Improvement - Example of changes and appropriate actions
  • 17. Three Stages in Proposed Lifecycle Approach Input of Design Procedure development Identify Potential Analytical Variables • Continuous Variables • Categorical Variables Experimental Robustness Study Analytical Procedures PPQ Protocol Experimental studies to demonstrate “fitness of purpose” (including local noise factor). PPQ Report and local analytical control strategy including the formal procedure. Routine Monitoring Action Trigger Investigation and CAPP Special Cause Variation Risk Assessment Unacceptable common cause variation Continuous improvement Stage-1: Procedure Design Development and Understanding Stage-2: Procedure Performance Qualification Stage-3: Procedure Verification Knowledge gathering and preparation (when a procedure is used in a new location) Change Type 1 Change Type 2 Change Type 3 Change Type 4 Change Type 5
  • 18. Current Approach • Focus is showing that various procedure performance characteristics meet criteria— but may not consider how these relate to the overall uncertainty in the data and whether they are acceptable or not. Lifecycle Approach • The driver is understanding the target measurement uncertainty, which is the maximum level of measurement uncertainty that represents fitness for purpose (i.e., ensures decisions from data are made with a predefined confidence) and to demonstrate the procedure will meet this uncertainty requirement. Current Approach • Tendency to perform validation in a check box manner against the general analytical performance characteristics described in and ICH Q2. Lifecycle Approach • Specific ATP for each measurement requirement defining the characteristics and criteria that the procedure should meet. Advantages of Adopting a Lifecycle Approach for Managing Analytical Procedures
  • 19. Current Approach • Limited understanding of effects of variation on performance. Lifecycle Approach • Structured and methodological approach to identify and explore variables. Current Approach • Validation, verification, and transfer are seen as separate exercises. Lifecycle Approach • All are integrated as part of the analytical procedure lifecycle, and success is demonstrated by generating reportable results that are consistent with the ATP. Advantages of Adopting a Lifecycle Approach for Managing Analytical Procedures Current Approach • Confusion about the differences among procedure validation, procedure transfer, and procedure verification. Lifecycle Approach • Improved clarity and holistic view with the ATP as the focal point.